Food pharmacy seals can be seen on April 22, 2025 at Hubert Humphry Building Auditorium in Washington, DC.
Jose Luis Magana/AP
Hide the caption
Caption toggle
Jose Luis Magana/AP
Washington-Federal officials have approved another general version of the abortion pill MIFEPRISTONE, a regulatory form that rapidly causes push bags from abortion groups and politicians.
Pharmaceuticals, EVITA SOLUTIONS, announced on the website that the food pharmacy has signed a low cost pill, which has been approved for 10 weeks of pregnancy.
Students for life behavior against abortion on Thursday were called “another sign of President Trump’s stain and the deep state of FDA.”
Josh Hawley, a Republican Senator of Missouri, also criticized X’s universe as “lost confidence in FDA’s leadership.”
The spokesman of the agency added, “The discretion is very limited in determining whether to approve the general medicine, and the FDA official said,” The FDA official does not guarantee the product. “
The criticism is increasing the pressure that the top health authorities of Donald Trump’s top health authorities, including Robert F. Kennedy Jr. Health, were approved 25 years ago by opposition to abortion and re -evaluated the US Pypis Stone, which was repeatedly considered by FDA scientists.
In a letter to the Republican Attorney General last month, Kennedy and FDA Chairman Dr. Marty Macari promised to review the drug’s safety.
Under Makary and Kennedy, the FDA has repeatedly delayed the decision of the vaccine and narrowed the approval of this year’s Covid-19 launch. This type of political intervention was very rare in the FDA, where career scientists generally make such a decision.
In 2000, the FDA approved Mifepristone’s original version and gradually relaxed access over time. This included the first general pill approval of pharmaceutical producer Genbiopro in 2019.
In 2021, the FDA of the Democratic Democratic Party’s FDA expanded the approach by allowing online prescriptions and mail orders to mail order of drugs. Abortion opponents have been fighting the change since then.
The approval of generic drugs is generally a ROTE process in the FDA, and after the patent for the original drug is generally approved, several copy cat versions are generally approved. In most cases, generic drugmakers only need to show that their drugs coincide with the ingredients used in the original drug.
Mini Timmaraju said, “This is exactly the way our system works and has been working in this way for decades.” FDA’s career scientists and civil servants have worked. “
The FDA usually approves these applications within 10 months. However, according to the documents published on the FDA website, Evita Solutions shows that four years ago submitted an application to MIFEPRISTONE Market.
EVITA said on the website, “I think everyone should be able to approach safe, inexpensive, high quality effective, effective and merciful abortion.”
The company expects drugs to be released in January next year.
The second generic approval will not generally affect the approach to the pills taken with other drugs, Misoprostol. This combination takes about two -thirds of American abortion. MIFEPRISTONE extends the cervix and blocks hormonal progesterone, while Misoprostol causes the uterus to cramps and contraction.
Access to MIFEPRISTONE is limited to large areas of the country due to the state law that prohibits abortion, including drug abortion, or imposes a separate restriction on drug use. This law applies a lot of progress suits that are on their way through the legal system.
Restrictions on pills are not supported by most major medical societies, including the American Medical Association.
